Sep 13, 2023 / 01:30PM GMT
Michael Eric Ulz - Morgan Stanley, Research Division - Equity Analyst
All right. Good morning, everyone, and thanks for joining us on day 3 at the Morgan Stanley Healthcare Conference. I'm Michael Ulz, one of the biotech analysts here. And it's my pleasure to introduce Fred Schwarzer, CEO of IGM Biosciences. Just a reminder, the format for today is a fireside chat. But before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, Fred, thanks for joining us today. And maybe I'll just turn it over to you to give us some brief background on IGM, and then we can get into some Q&A.
Fred M. Schwarzer - IGM Biosciences, Inc. - CEO, President & Director
Great. Well, thanks, Mike. I really appreciate the opportunity to present here.
IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers